Skip to main content

Table 1 Demographic and baseline characteristics of the patients

From: Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: A parallel, randomized, double blind study

Variables

Formulation A

Formulation B

Total

p

N

17

17

34

 

Age (years)

52 ± 15 (19–72)

52 ± 16 (23–75)

52 ± 15 (19–75)

0.90*

Weight (Kg)

60 ± 12 (40–87)

59 ± 13 (42–83)

59 ± 12 (40–87)

0.82*

Sex

Male

11 (64.7%)

8 (47.1%)

19 (55.9%)

0.30Δ

 

Female

6 (35.3%)

9 (52.9%)

15 (44.1%)

 

Race

White

8 (47.1%)

10 (58.8%)

18 (52.9%)

0.73!

 

Non-white

9 (52.9%)

7 (41.2%)

16 (47.1%)

 

Smoking

4 (23.5%)

1 (5.9%)

5 (14.7%)

0.33!

Alcohol consumption

4 (23.5%)

1 (5.9%)

5 (14.7%)

0.33!

Coffee drinking

7 (41.2%)

7 (41.2%)

14 (41.2%)

1.00Δ

Causes of renal failure

    

Diabetes Mellitus

7 (46.7%)

6 (40.0%)

13 (43.3%)

0.71Δ

Hypertension

5 (33.3%)

4 (26.7%)

9 (30.0%)

1.00!

Other glomerulopathies

1 (6.7%)

1 (6.7%)

2 (6.7%)

1.00!

Cystic disease

1 (6.7%)

3 (20.0%)

4 (5.6%)

0.60!

  1. Data are reported as mean ± standard deviation (range) or number of patients (%).
  2. *: Student's t test; Δ: chi-square test; !: Fisher's exact test